29 Jul GSK Arexvy Update and Webinar Opportunity
GSK announces an expanded indication for Arexvy, and invites PAA members to register for their RSV Awareness Webinar Series, The Risk of Respiratory Syncytial Virus (RSV): Disease Burden and Vaccination. Log in to learn more and to register.